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ABSTRACT

EFFECTS OF ENDURANCE TRAINING ON THE AMPK RESPONSE TO
EXERCISE

David G. Chesser
Department of Physiology and Developmental Biology
Master of Science

Activation of AMP-activated protein kinase (AMPK) results in the
upregulation of several intracellular systems which help to prepare a cell for a high
energy challenge. The magnitude of the AMPK response to a 10 min bout of exercise
has been found to decrease in red quadriceps (RQ) following training, while putative
AMPK roles seem to be maintained; specifically, the biogenesis of mitochondria and
higher levels of hexokinase II and glucose transporter 4 (GLUT4). If the AMPK
response to exercise is responsible in part for these adaptations, how can they be
maintained if the AMPK response is attenuated? The purpose of this study was to
determine whether phosphorylation of AMPK in RQ increases during 2-hr training
bouts after rats have trained for 8 wks. Male Sprague-Dawley rats ran up to 30 m/min
up a 15% grade, 2 hr/day for 8 wks. On the final bout of exercise, trained rats ran for 0
(TRC), 30 (TR1), or 120 min (TR2) up a 15% grade at 30 m/min. Red quadriceps
(RQ), soleus, and white quadriceps (WQ) were immediately collected and frozen for
analysis. Citrate synthase activity increased in RQ (79 ± 3 vs. 37 ± 4 μmol/g/min) and

soleus (64 ± 4 vs. 35 ± 2 μmol/g/min) but not in WQ compared to non-trained controls.
In trained rats, maximal increases in T-172 phosphorylation of AMPK occurred after
30 min of exercise (relative values = 1.29 ± 0.06 vs. 1.00 ± 0.06). AMPK
phosphorylation did not change significantly in trained rats that ran for 2 hrs (1.31 ±
0.09) compared to rats that ran for 30 min. Similarly, maximal increases in AMPK
activity in trained rats occurred after 30 min of exercise (pmoles/min/mg = 2.67 ± .05
vs. 1.09 ± .41) and AMPK activity did not change significantly in trained rats that ran
for 2 hrs (2.79 ± .17) compared to rats that ran for 30 min. Previous studies
demonstrated a 2−3 fold increase in AMPK activity in non-trained rats after 30 min of
exercise at lower work rates. These results demonstrate that the AMPK response to
exercise is attenuated even after two-hr bouts of exercise. This implies that the
increase in mitochondrial oxidative enzymes, GLUT4, and hexokinase II may be
maintained by signals other than the AMPK signaling system. The CREB signaling
pathway is one such system. Western analysis of phospho-CREB (Ser133) showed a
statistically significant increase in phospho-CREB content in trained rats relative to
control. No change in phospho-CREB protein expression was observed between TRC,
TR1, and TR2 rats. Significant increases of muscle phospho-CREB content in TRC
relative to untrained rats suggest that CREB remains phosphorylated in trained rats
even after 24 hrs of rest. Accordingly, chronically increased phospho-CREB in muscle
of trained rats relative to controls may explain in part how increased levels of
mitochondria are maintained in the face of reduced AMPK response. Alternatively, the
attenuated AMPK response may still be above the threshold required for inducing
adaptations to endurance training.
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PROSPECTUS

INTRODUCTION
The 5’-AMP-activated protein kinase (AMPK) acts as a metabolic master
switch regulating several intracellular systems including the cellular uptake of glucose,
the β-oxidation of fatty acids and the biogenesis of glucose transporter 4 (GLUT4) and
mitochondria (1, 2, 4, 5, 36). The energy-sensing capability of AMPK can be
attributed to its ability to detect and react to fluctuations in the AMP:ATP ratio that
take place during rest and exercise (muscle stimulation). During muscle contraction
AMP increases while ATP decreases, which changes AMPK into a good substrate for
activation via an upstream kinase, AMPKK. AMPKK is a complex of three proteins,
STE-related adaptor (STRAD), mouse protein 25 (MO25), and LKB1 (a
serine/threonine kinase). During a bout of exercise, muscle AMPK activity increases
in response to metabolic stress brought about by an extreme cellular demand for ATP.
This AMPK response to exercise has been found to notably decrease following
training while putative AMPK roles seem to be maintained such as GLUT4 and
mitochondrial biogenesis (3). One possible explanation for the attenuating effects of
training on the AMPK response to exercise is that perhaps the immediate metabolic
stress felt by a trained muscle cell during stimulation has been reduced due to the
increase in GLUT4, blood supply, mitochondria and other adaptations that the
endurance training itself induced upon the cell. This condition would bring about a
delayed AMPK response to the exercise bout until the metabolic stress equates to that
of an untrained cell. It has already been found that high-intensity work rates are
needed for AMPK activation (6, 7, 8, 9). We hypothesize that these necessary high-
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intensity conditions for AMPK activation will need to increase higher still with
training. This study will investigate the effects that endurance training has on the
AMPK response to exercise and its effects on other enzymes that take on key
metabolic roles as well. This will include a comparative study that will examine the
AMPK response to exercise at different stages of the final exercise bout following
training. The foremost health related impact we hope to receive from this study
includes the substantiation of an AMPK role in long-term exercise-induced adaptation
mechanisms which may perhaps lead to improvements in certain metabolic aberrations
in metabolic diseases.

AMPK
The heterotrimeric protein AMPK is composed of α, β, and γ subunits. Each of
these three subunits takes on a specific role for both the stability and activity of
AMPK (11). The γ subunit includes four particular cystathione beta synthase (CBS)
domains giving AMPK its ability to sensitively detect shifts in the AMP:ATP ratio.
The four CBS domains create two binding sites for AMP commonly referred to as
Bateman domains. Binding of one AMP to a Bateman domain cooperatively increases
the binding affinity of the second AMP to the other Bateman domain (49). As AMP
binds both Bateman domains the γ subunit undergoes a conformational change which
exposes the catalytic domain found on the α subunit. It is in the activation loop of the
catalytic domain where AMPK becomes activated when phosphorylation takes place
at threonine-172 by an upstream AMPK kinase (AMPKK) (19). The α, β, and γ
subunits can also be found in different isoforms: α1 or α2, β1 or β2, and γ1, γ2, γ3.
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Although the most common isoforms expressed in most cells are the α1, β1, and γ1
isoforms, it has been demonstrated that the α2, β2, γ2, and γ3 isoforms are also
expressed in cardiac and skeletal muscle (11, 12, 13).

AMPK ACTIVATION
Triggering the activation of AMPK can be carried out provided that two
conditions are met. First, the γ subunit of AMPK must undergo a conformational
change so as to expose the active site (Thr-172) on the α subunit. The conformational
change of the γ subunit of AMPK can be accomplished by an increase in [AMP].
Increased concentrations of AMP will give rise to the conformational change on the γ
subunit of AMPK as two AMP bind the two Bateman domains located on that subunit.
It is this conformational change brought about by increased concentrations of AMP
that exposes the active site (Thr-172) on the α subunit. This critical role of AMP is
further substantiated in experiments that demonstrate AMPK activation via an AMP
analogue 5-amino-4-imidazolecarboxamide ribotide (ZMP) which is derived from 5amino-4-imidazolecarboxamide riboside (AICAR) (14, 15, 16, 17). The second
condition that must be met is the phosphorylation and consequent activation of AMPK
on its activation loop at Thr-172 of the α subunit brought about by an upstream kinase
(AMPKK) (19, 20). The complex formed between LKB1 (STK 11), mouse protein 25
(MO25), and the pseudokinase STE-related adaptor protein (STRAD) has of late been
identified as the major upstream kinase responsible for phosphorylation of AMPK on
its activation loop at Thr-172 (21, 22, 23). AMP also makes AMPK a poorer substrate
for phosphatases (19, 20, 24).
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Muscle contraction can provide the conditions mentioned above needed for
AMPK activation (25). As muscles contract, ATP is hydrolyzed, forming ADP. ADP
then helps to replenish cellular ATP by donating a phosphate group to another ADP,
forming an ATP and an AMP. As more AMP is produced during muscle contraction,
the AMP:ATP ratio dramatically increases, leading to the allosteric activation of
AMPK (10, 26, 27). This fact is further authenticated with studies, such as those sited
above, that used electrical stimuli as a means to contract muscle to facilitate AMPK
activation (1, 6, 18, 28, 29).

FUNCTION OF AMPK WITH EXERCISE/TRAINING
Many biochemical adaptations of skeletal tissue take place in response to
endurance training [increased mitochondrial biogenesis and capacity (31, 32),
increased muscle glycogen (37), and an increase in factors which specialize in glucose
uptake in cells such as GLUT4 and Hexokinase II (33, 35, 37) are thought to be
mediated in part by AMPK when it is activated (2, 34). Additionally, recent
discoveries can conceivably suggest a direct AMPK role in increasing blood supply to
exercised/trained muscle cells by stimulating and stabilizing both vasculogenesis and
angiogenesis (30). Taken together, these adaptations most likely transpire as a result of
both temporary and maintained increases in AMPK activity brought about by
increases in the AMP:ATP ratio during single bouts of exercise and long-term training.
During a single acute exercise bout, AMPK takes on immediate roles to allow
the contracting muscle cells adapt to the energy challenges taking place by inducing
GLUT4 translocation to the plasma membrane (28, 40, 41, 42) allowing for increased
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glucose uptake. It has also been found that AMPK can help stimulate glycolysis in
heart muscle (50). If exercise bouts continue through a long-term training regimen,
AMPK and other signals will increase mitochondrial oxidative proteins, thus
increasing capacity to produce ATP. AMPK accomplishes this transition to the
oxidative mode of metabolism by upregulating and activating enzymes that are known
to be involved (either directly or indirectly) in the oxidation of glucose and fatty-acids
such as GLUT4, hexokinase II, PPARalpha, PGC-1, UCP-3, cytochrome C and
TFAM, just to name a few (2, 35, 37, 38, 39, 43).

AMPKK AND EXERCISE/TRAINING
AMPK activity increases with exercise and the LKB1/MO25/STRAD complex
is considered to be the major upstream AMPKK of the 5’-AMP-activated protein
kinase phosphorylating the α subunit of AMPK at Thr-172 (19, 20, 21, 22). This fact
is puzzling considering that although LKB1 protein abundance has been shown to
increase in skeletal tissue with endurance training, AMPKK and AMPK activities
have been shown to decrease with endurance training in both trained and untrained
tissue (18, 29, 45, 46). Currently, the activity of AMPKK immediately following a 2hr bout of exercise of an endurance trained rat is unclear. It is possible that there exists
a direct link between the observed decrease in AMPKK activity in endurance trained
skeletal muscle and the apparent decrease in the AMPK response to exercise with
endurance training. AMPKK activity assays will be run to assess this possibility
following training.
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PROPOSAL
A seemingly paradoxical role of AMPK occurs when we take a closer look at
the energy-sensing enzyme in relation to exercise and long-term training. Long-term
endurance training triggers increases in muscle oxidative metabolic enzymes and
increases in GLUT-4, mitochondrial size and quantity, and an increased capacity for
oxidation of fatty acids; however, Winder et al. reported in 2002 that despite observing
these increased oxidative biochemical adaptations to long-term endurance training
(similar to those mentioned above), the AMPK response (activation of AMPK with the
onset of exercise) to acute bouts of exercise decreased in red quadriceps (RQ) with
training (3 – see Fig.1). Conversely, the study did not observe the same results in
white quadriceps (WQ) and soleus (SOL) muscles that they did in RQ. The trained rats
used for that endurance study ran on treadmills 5 days/wk in two 1-h sessions,
morning and afternoon. The rats were also running up to 31m/min (grade 15%).
Finally, following training, the rats were sacrificed either at rest or following 10 min.
of exercise.
Because the AMPK response to exercise decreases with increased training
duration, many questions arise that would challenge the AMPK role with respect to
biochemical adaptations to exercise and endurance training. If the AMPK response to
exercise is responsible in part for biochemical adaptations to training, how then can
these adaptations to training be maintained if the AMPK response to exercise is being
attenuated with training? It is hypothesized that in endurance trained rats, the increase
in AMPK during each bout of exercise will be delayed as a result of the increase in
mitochondrial oxidative enzymes. Therefore, we will run trained rats for a longer
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duration (up to a 2-h bout of exercise) in order to determine if AMPK is activated late
in the course of prolonged training bouts. Rats will be killed at rest and after running
30 min and 120 min. By doing this we hope to observe and capture the 5’-AMPactivated protein kinase (AMPK) in its now active state in RQ following a high
intensity long-term training procedure.

TRAINING PROTOCOL & ANTICIPATED EXPERIMENTS
1) Rat Training Protocol & Tissue Homogenization- All rats will be
trained appropriately according to the Institutional Animal Care and Use
Committee of Brigham Young University. 30 male Sprague-Dawley rats
(Sasco, Wilmington, MA) will be housed in a reasonably quiet,
temperature controlled (21-22°C) room that cycles daily with a 12-h light
and 12-h dark period. Rats will be kept in Institutional Animal Care and
Use approved rodent shoebox compartments (two rats per compartment)
with a metal grill top to allow for ventilation. Rodent bedding will be
replaced in each shoebox up to two times a week and all rats will be
weighed every week to keep a log of rat growth rate. Rats will be fed
standard rat chow (Harlan Teklad rodent diet) and given water to drink ad
libitum. Trained rats will be given 30 g of rat chow the night before they
are killed to help measure blood glucose levels. 20 randomly assigned rats
will run on a motor-driven rodent treadmill up a 15% grade 5 days/wk for
8-10 weeks in a temperature controlled room (16-17°C). Initially, the rats
will run for 35-m the first day up a 5% grade at 16 m/min. Exercise bout
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intensity will increase daily until the rats eventually progress to a single
120-m bout of exercise on a 15% grade at 32 m/min. Rat training at this
point will be maintained for 4 more weeks. After 8-10 weeks, blood and
tissue samples (left/right gastrocnemius, left/right red/white quadriceps,
left/right Soleus, Liver and Heart) will be collected from trained rats
anesthetized either at rest or immediately following a 30-m or 2-h bout of
exercise by intravenous (jugular catheter) injection of pentobarbital sodium.
The catheters will have been placed in the jugular veins (fastened tightly
with sterilized string) of trained rats anesthetized with Isoflurane, USP
(liquid for inhalation) 3 days prior to sacrifice. Once extracted, tissues will
be compress frozen with metal tongs at liquid nitrogen temperature (appx. 196°C), wrapped immediately in labeled aluminum foil and then placed in
a container filled with liquid nitrogen until they are stored later in an
temperature ultra-low temperature (-90°C) freezer. Untrained rats will be
anesthetized with pentobarbital sodium (50mg/kg body wt) and tissues
(right red/white Quadriceps and right Soleus) will be extracted and clamp
frozen at liquid nitrogen temperature. Untrained tissues will be used as a
control to compare with trained tissues for proteins such as p-eEF2K, p-GS,
p-IRS-1, p-TSC2, p-ACC hexokinase, cytochrome C, FAT/CD36, GLUT4,
AMPK, ACC, PGC-1, MO25, STRAD, LKB1, AS160 and TFAM. Citrate
synthase activity will be measured and used to confirm a training effect in
the trained rats. All tissues will be ground with a mortar and pestle at liquid
nitrogen temperature and then homogenized in a homogenization buffer
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containing 250 mM mannitol, 50 mM Tris-HCl, 50 mM NaF, 5 mM NaPPi,
1 mM EDTA, 1 mM EGTA, and 1% triton all at a pH of 7.4. Dithiothreitol
(DTT) (1 mM), 1 mM Benzamidine, 1μg/ml soybean trypsin inhibitor,
and .5 mM AEBSF are added just prior to homogenization. The final
concentration of the tissue in the homogenization buffer solution will be a
9 factor dilution (1 g muscle powder / 9 ml buffer). Approximately 300 μl
of raw homogenate will be taken from the homogenate and the rest will
then be centrifuged at 2100 rpm for 20-min at 4°C. Post-centrifugation,
supernatant from the homogenate will be immediately taken from the tubes
and aliquots will be dispensed into 1500 μl Eppendorf tubes.
2) Western Blots- Blots from trained rats will be performed on p-eEF2K, pGS, p-IRS-1, p-TSC2, p-ACC GLUT4, AMPK, phospho-AMPK, ACC,
PGC-1, cytochrome C, MO25, STRAD, LKB1, AS160, TFAM,
FAT/CD36 and Hexokinase. From untrained rats we will run western blots
for hexokinase, GLUT4 and citrate synthase. By looking at the abundances
of these enzymes relative in the skeletal muscles at a range of different
stages in the exercise training we will help elucidate the regulation of
AMPK during a long-term exercise training protocol. Many of the other
enzymes listed above, which also take on key roles for metabolic
adaptations in muscle cells, have never been looked at immediately
following a 2-h high-intensity exercise bout following an endurance
training protocol.
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3) Citrate Synthase Assay- Citrate synthase catalyzes the reaction between
oxaloacetate, Acetyl-CoA and water to form citrate and can be used as a
quantitative enzyme marker for the presence of mitochondria in trained
muscle tissue. In this assay we will be able to confirm our rats were trained
by measuring the citrate synthase activity. Citrate synthase activity in
trained rats, when compared to untrained rats, will be significantly higher if
in fact the rats are trained.
4) Lactate Assay- Formation of lactate in muscle cells is in part due to the
enzyme lactate dehydrogenase (LDH) and rate of formation increases when
the muscle cell cannot meet energy demands via aerobic respiration.
Measuring the concentration of lactate in both muscle tissue and the blood
will be able to tell us about the oxidative capacity of the tissue which we
anticipate to be higher with the trained rats.
5) Glycogen Assay- Both liver and muscle cells contain stores of glycogen
granules in their cytosol. Liver cells are unique because they carry the
highest concentration of glycogen out of all of the tissues in the body and
they have the ability to break down their glycogen stores into glucose
molecules, which can be passed into the blood stream for use by other
tissues that need them. Muscle cells do not have the ability to pass glucose
directly into the blood stream, suggesting that their glycogen stores are
intended as an immediate reserve source of glucose. Measuring levels of
muscle glycogen concentration in our trained rats will tell us how much
glycogen the trained rats are storing in muscle, and it will also help confirm
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that muscle cells were utilizing the oxidative mode to metabolism later on
in the exercise bouts.
6) AMPKK Activity Assay- One of the main objectives of this research is to
capture AMPK in its activated state immediately following a 2-h high
intensity exercise bout following training. Measuring AMPKK activity in
this assay will be essential in confirming a possible link between the
apparent reduction in the AMPK response to exercise following highintensity endurance training. Alternatively, if in other experiments we
observe an increased AMPK response to exercise immediately following
an intense exercise bout, then we would also expect an increase in AMPKK
activity. In addition, AMPKK activity will be measured from muscle
homogenates taken at different stages of the final high-intensity exercise
bout to observe the regulatory behavior of AMPKK activity during
exercise.
7) AMPK Activity Assay- Measuring the activity of AMPK following
training is the main experiment underlying the purposes of this study.
Measuring p-AMPK via western blot will not be enough to know for
certain just how active AMPK is following training. AMPK activity will be
measured from trained muscle homogenates taken at different stages of the
final high-intensity exercise bout to observe any fluctuations in AMPK
activity in response to the exercise. If AMPK activation is delayed due to
the physiological adaptations present in the contracting muscle, then we
should observe an increase in AMPK activity in trained rats ran for the full
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2 hrs on the final day of training (if at all) relative to the trained rats ran for
30 min or those trained rats that did not run at all on the final day.

METHODS
1) Western Blot- Samples (raw homogenate / supernatant) are mixed with 1
X loading buffer that has been heated to 50°C for appx. 5-m. The samples
are then loaded into wells of an appropriate percent Tris-HCl, ready-made
Criterion® gel. The proteins in the sample are then separated via SDSPAGE for appx. 45-m at 200 V or until optimal separation is observed.
Immediately after electrophoresis, gels are rinsed in Transfer Bx (4°C) and
properly placed in a protein transfer sandwich (fiber paper, filter paper, gel,
PVDF membrane, filter paper, fiber paper). Proteins will then be
transferred to PVDF membrane in mixing temperature controlled (4°C)
Transfer Bx for 1-h at 100 V. Blocking solution (1.25 non-fat dried milk /
25 ml PBST) is prepared (pH 7.6) while transferring is taking place.
Immediately following transfer, membranes are stained with PONCEAU to
confirm a successful transfer, washed and then allowed to incubate in
blocking solution for 1 hr at room temperature. While blocking is taking
place the correct primary antibody is prepared. After blocking, the
membrane is washed for 30-m with PBST and PBS and then the membrane
is incubated overnight with the primary antibody at 4°C. The next day the
membrane is washed for 30-m with PBST and PBS and then allowed to
incubate for one more hour with the correct secondary antibody with a
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Horseradish Peroxidase (HRP) tag. Immediately following incubation, the
membrane is washed one last time for 30-m with PBST and PBS. The
membrane is then exposed for 1-m to a hydrolytic detecting solution (ECL)
which will react with HRP and produce light on the membrane. Last of all,
the membrane is quickly exposed to developing film in a dark room for the
necessary time and the film is then developed, revealing the blot pattern.
All blots will be summarized on blot reports and significance will be
calculated.
2) AMPKK Activity Assay- The two-step process of the standard AMPKK
activity assay includes the phosphorylation of AMPK and then the
subsequent phosphorylation of AMARA peptide by phospho-AMPK (45,
48). In this assay we will be using the bacterially expressed heterotrimeric
r-AMPK (recombinant AMPK) in the α2β2γ2 isoform as the AMPKK
substrate. We will be able to measure activation of the r-AMPK substrate
through the incorporation of a radioactive phosphate group (32P) from ATP
into the AMARA peptide serving as the AMPK substrate (19). Tissue
homogenates will be diluted 1:1 (vol/vol) in AMPK storage buffer and then
2 μl will be incubated with r-AMPK in 4 μl AMPKK assay buffer for 20-m.
15 μl of phosphorylation buffer will then be added, and the reaction will
end by spotting 1-cm2 pieces of pre-cut P81 filter paper (Whatman,
Tewksbury, MA) with 15 ul of the final reaction mixture after 10-m.
Finally, the filter papers will be washed 6 times in stirring 100 ml 1%
phosphoric acid. The
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phosphoric acid will be neutralized with Sodium Bicarbonate while the
Whatman papers are rinsed with acetone and allowed to dry. After the
papers are dry they will be placed in 3 ml of Ecolite (ICN, Irvine, CA) and
then counted for 1-m on a scintillation counter.
3) Muscle Glycogen Assay- Frozen tissue samples will be ground to powder
under liquid nitrogen with a mortar and pestle. 100 mg of ground tissue
will be weighed out and incubated for 30-m in 0.5 ml cold 30% KOH with
a marble cap. After 30-m the muscle mixture will be neutralized with 10.7
M acetic acid (~.55 ml). Once neutralized, 0.1 ml of mixture will be
transferred to a 12 X 75 mm tube containing 0.9 ml amyloglucosidase
buffer, capped and then incubated for 1-h at 55°C. Tubes are then
centrifuged for 10-m prior to 0.1 ml being transferred to a cuvette
containing 0.88 ml reaction buffer for an absorbance reading. Absorbance
is read at an O.D. of 340 nm on a spectrophotometer. 15-m after the first
readings, a final absorbance reading is measured with the addition of 0.02
ml G6PDH and HK enzyme mixture that has been mixed by inversion.
From the O.D. results we will then be able to calculate µmoles glucose
(from glycogen)/g tissue.
4) Citrate Synthase Assay- This is a comparative assay using two different
amounts of the homogenate to assess linearity with the amount of enzyme.
In general, a cuvette is filled with 0.60 ml 100 mM Tris (pH 8.0), 0.10 ml
3.0 mM Acetyl-CoA, 0.10 ml 1.0 mM DTNB, and 0.10 ml diluted red
quadriceps homogenate. The cuvette is then covered with parafilm, mixed
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by inversion several times and then placed in a thermostated (30° C)
chamber of the spectrophotometer for 7-m. The change in O.D. is then
recorded for 2-m at 30-s intervals at 412 mΦ. The reaction is started by
adding 0.10 ml of 5 mM oxaloacetate and then mixed by inversion several
times. This reaction mixture is then placed into the spectrophotometer to
record the O.D. change over 3-m at 30-s intervals. Citrate synthase levels
can then be calculated from the O.D. fluctuations observed on the
spectrophotometer.
5) Muscle Lactate Assay- Like the muscle glycogen assay I will weigh out
100 mg muscle powder and add it to a cold homogenizing tube with 1 ml
6% PCA solution. The mixture is homogenized and centrifuged, and then
0.8 ml is added to a 12 x 75 mm tube. The resulting solution is neutralized
to pH ~7 by adding approximately 0.35 ml 2 M KOH, 0.4 M KCl and 0.4
M imidazole. The solution is then centrifuged and frozen, and the
supernatant is saved for analysis. The supernatant is measured for lactate
by adding 0.10 ml neutralized muscle extract and 0.88 ml reaction mix.
The mixture is inverted 20 times with a parafilm cap. After mixing, the
solution’s initial O.D. is read. After the initial reading a final O.D. reading
is taken after adding 0.01 ml LDH solution. With the initial and final O.D.
readings, the µmoles lactate / g tissue can then be calculated.
6) IP AMPK Activity Assay- AMPK will be isolated by
immunoprecipitation from spun cell homogenate of all rats participating in
the study. G-sepharose bound to anti-AMPK-α2 will be evenly divided into

15

1.5 ml eppendorf tubes and allowed to incubate with spun homogenate
taken from each rat overnight on a ferris wheel shaker at 4°C. This will
allow for the immunoprecipitation of AMPK- α2 from the homogenate
mixtures. The following day, the immunoprecipitates will be washed with
ice-cold IP buffer + 1M NaCl to clear out non-specific proteins. Next, the
immunoprecipitates will be evenly aliquotted in duplicate into 12 x 75
glass tubes. 25 μl working AMPK assay cocktail (SAMS peptide, AMP,
ATP, DTT, and P32-ATP) is then added to the tubes and allowed to shake
for 10 min at 37°C. After the reaction mixture has been allowed to shake,
15 μl from each tube will be transferred to labeled 1X1 cm Whatman P81
filter paper. The filter papers will then be rinsed 5 times in fresh 1%
phosphoric acid, washed once with acetone, and allowed to dry. Dry papers
are placed face up in scintillation vials containing 3 ml EcoLite scintillation
cocktail (ICN Research Products Division, Costa Mesa, CA), placed in a
Beckman scintillation counter, and counted for 5 min each. AMPK activity
was measured based off of the counts measured per minute.
7) Buffers- Often DTT, Benzamidine, AEBSF and soybean trypsin inhibitor
will be added to buffers just prior to use in order to inhibit protease activity.
Muscle Homogenization Buffer: 250 mM mannitol, 50 mM Tris-HCl, 50
mM NaF, 5 mM NaPPi, 1 mM EDTA, 1 mM EGTA, 1% triton all at a pH
of 7.4.
4 x Loading Buffer (92% stock soln.): 240 mM Tris-HCl, 8% SDS
(sodium dodecyl sulfate), 40% Glycerol, .04% bromophenol blue all at a
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pH of 6.8. Add 8% β-mercaptoethanol just prior to use to bring the buffer
to 100% stock solution.
1 x Transfer Buffer (20% MeOH): 48 mM TRIS, 39 mM Glycine, .074%
SDS, 20% Methanol, pH 9.0.
100 mM Tris Buffer, pH 8.0: 4.02 grams Trizma HCl + 2.97 grams
Trizma Base diluted to 500 ml with distilled water. Adjust to final pH with
HCl or KOH.
Amyloglucosidase buffer: (fresh daily - keep cold): Add 100 µg
amyloglucosidase to 1 ml distilled water. Allow to dissolve. Add 0.1 ml
from this solution to 10 ml, 50 mM acetate buffer pH, 4.7.
Phosphorylation Buffer: 40 mM Hepes, 80 mM NaCl, 8% glycerol, 0.8
mM EDTA, 0.8 mM DTT, 5 mM MgCl2, 0.2 mM AMP, 0.2 mM ATP,
0.33 mM AMARA peptide, 0.05 μCi/μl [γ32]ATP, pH 7.0.
1 X Phosphate-buffered Saline (PBS): 138.6 mM NaCl, 2.71 mM KCl,
2.15 mM KH2PO4, 9.89 mM Na2HPO4, pH 7.3.
1 X PBST: Same as PBS but add 0.1% Tween20.
IP Buffer: 50 mM Tris-HCl, 150 mM NaCl, 50 mM NaF, 5mM Na
pyrophosphate, 1 mM EDTA, 1 mM EGTA, 1 mM DTT, 1 mM DTT, 1
mM benzamidine, 0.1 mM PMSF, 5 ug/ml soybean trypsin ingibitor, pH
7.4.
Hepes Buffer: 25 MM HEPES, 0.02% Brij, 1 mM DTT, pH 7.0.
Stock Solution: 100 mM HEPES, 200 mM NaCl, 20% glycerol, 2 mM
EDTA, 12.5 mM MgCl2, pH 7.0.
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Working Assay Cocktail: 0.5 mM AMP, 2 mM DTT, 0.5 mM ATP in
stock solution. 1 mM SAMS peptide and 10 mCi/ml P32-ATP is added just
before running the assay.
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ESTIMATED COSTS
Western Blots•

Developing reagents ~ $4,000.

•

Antibodies net worth ~ $4,500.

AMPKK Activity Assay•

Reagents ~ $1,000.

Muscle Glycogen Assay ~ $100.
Citrate Synthase Assay ~ $100.
•

Acetyl-CoA ~ $400.

Muscle Lactate Assay ~ $100.
AMPK Activity Assay ~ $2000
•

P32-ATP ~ $300
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ABSTRACT
Activation of AMP-activated protein kinase (AMPK) results in the upregulation of
several intracellular systems which help to prepare a cell for a high energy challenge.
The magnitude of the AMPK response to a 10 min bout of exercise has been found to
decrease in red quadriceps (RQ) following training, while putative AMPK roles seem
to be maintained; specifically, the biogenesis of mitochondria and greater expression
of hexokinase II and glucose transporter 4 (GLUT4) in the muscle fiber. If the AMPK
response to exercise is responsible in part for these adaptations, how can they be
maintained if the AMPK response is attenuated? The purpose of this study was to
determine whether phosphorylation of AMPK in RQ increases during 2-hr training
bouts after rats have trained for 8 wks. A maximized AMPK response after a 2-hr bout
of exercise in endurance-trained rats could account for these adaptations. Male
Sprague-Dawley rats ran up to 30 m/min up a 15% grade, 2 hr/day for 8 wks. On the
final bout of exercise, trained rats ran for 0 (TRC), 30 (TR1), or 120 min (TR2) up a
15% grade at 30 m/min. Red quadriceps (RQ), soleus, and white quadriceps (WQ)
were immediately collected and frozen for analysis. Citrate synthase activity increased
in RQ (79 ± 3 vs. 37 ± 4 μmol/g/min) and soleus (64 ± 4 vs. 35 ± 2 μmol/g/min) but
not in WQ compared to non-trained controls. In trained rats, maximal increases in T172 phosphorylation of AMPK occurred after 30 min of exercise (relative values =
1.29 ± 0.06 vs. 1.00 ± 0.06). AMPK phosphorylation did not change significantly in
trained rats that ran for 2 hrs (1.31 ± 0.09) compared to rats that ran for 30 min.
Similarly, maximal increases in AMPK activity in trained rats occurred after 30 min of
exercise (pmoles/min/mg = 2.67 ± .05 vs. 1.09 ± .41) and AMPK activity did not
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change significantly in trained rats that ran for 2 hrs (2.79 ± .17) compared to rats that
ran for 30 min. Previous studies demonstrated a 2−3 fold increase in AMPK activity in
non-trained rats after 30 min of exercise at lower work rates. These results
demonstrate that the AMPK response to exercise is attenuated even after two-hr bouts
of exercise. This implies that the increase in mitochondrial oxidative enzymes,
GLUT4, and hexokinase II may be maintained by signals other than the AMPK
signaling system. The CREB signaling pathway is one such system. Western analysis
of phospho-CREB (Ser133) showed a statistically significant increase in phosphoCREB content in trained rats relative to control. No change in phospho-CREB protein
content was observed between TRC, TR1, and TR2 rats. Significant increases of
muscle phospho-CREB content in TRC relative to untrained rats suggest that CREB
remains phosphorylated in trained rats even after 24 hrs of rest. Accordingly,
chronically increased phospho-CREB in muscle of trained rats relative to controls may
explain in part how increased levels of mitochondria are maintained in the face of
reduced AMPK response. Alternatively, the attenuated AMPK response may still be
above the threshold required for inducing adaptations to endurance training.

Keywords: AMPK, GLUT4, hexokinase II, mitochondria, CREB
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THESIS

INTRODUCTION
The heterotrimeric, 5’-AMP-activated protein kinase (AMPK) is composed of
α, β, and γ subunits. Each of these three subunits takes on a specific role for both the
stability and the activity of AMPK (40). The γ subunit plays a particularly important
role during exercise because it includes four cystathione beta synthase (CBS) domains.
The four CBS domains create two binding sites for AMP, commonly referred to as
Bateman domains. Binding of one AMP to a Bateman domain cooperatively increases
the binding affinity of the second AMP to the other Bateman domain (1). The α, β, and
γ subunits can be found in different isoforms: α1 or α2: β1 or β2: and γ1, γ2, γ3.
Although the α1, β1, and γ1 isoforms are the most common expressed in most cells, it
has been demonstrated that the α2, β2, γ2, and γ3 isoforms are also expressed in
cardiac and skeletal muscle (7, 40, 49). The α2-containing AMPK complex
(AMPKα2) is considered the foremost AMPK isoform responsible for the metabolic
adaptations to training and exercise in contracting skeletal muscle (13, 41, 56).
The energy-sensing capability of AMPK can be attributed to its ability to
detect and react to fluctuations in the AMP:ATP ratio that take place during rest and
exercise (muscle contraction) (37). AMPK is sensitive to the fluctuating (increasing)
AMP:ATP ratio during exercise because AMP acts as an allosteric activator of AMPK
(52), while ATP inhibits AMPK activation by binding to the Bateman domains on the
γ subunit (14). As AMP binds both Bateman domains, the γ subunit undergoes a
conformational change that exposes the catalytic domain found on the α subunit.
Subsequently, this action allows AMPK to become activated in the activation loop of
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the catalytic domain when phosphorylation takes place at threonine-172 by an
upstream AMPK kinase (AMPKK) (16, 41, 54). Because increases in AMP
concentrations in contracting skeletal muscle usually correlate with small decreases in
ATP, AMPK will become activated either when energy demands needed for exercise
are not met or when they are in short supply. Upon activation by AMPKK, AMPK
serves as a metabolic master switch regulating several intracellular adaptations to
muscle contraction.
Major responses to exercise and adaptations to endurance training effectuated
by AMPK include the cellular uptake of glucose (17, 18, 25, 28), the β-oxidation of
fatty acids, and the biogenesis of GLUT4 and mitochondria (4, 31, 48, 52, 53).
Adaptations of skeletal tissue that take place in response to endurance training
[increased muscle glycogen (21), increased PGC-1 (2, 45-47), hexokinase II (4, 21,
35), UCP-3 (42), cytochrome C (5, 6, 20), as well as increased activities of
mitochondrial enzymes such as citrate synthase, succinate dehydrogenase, and malate
dehydrogenase (55)] are also thought to be mediated in part by activated AMPK.
Furthermore, recent discoveries suggest a direct AMPK role in increasing blood
supply to exercised/trained muscle cells by stimulating and stabilizing both
vasculogenesis and angiogenesis (32). Aside from upregulating these pathways that
result in the generation of ATP during exercise, AMPK also acts to downregulate
synthetic pathways that consume ATP (8, 9, 26, 29, 57). Together, these adaptations
serve to decrease the high energy demands in muscle tissue felt during exercise and
endurance training. Both the rapid/acute and chronic/long-term effects of AMPK
activation most likely transpire in part as a result of both temporary and maintained
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increases in AMPK activity brought about by increases in the AMP:ATP ratio during
single bouts of exercise and long-term training.
During a bout of exercise, muscle AMPK activity increases in response to
metabolic stress brought about by an extreme cellular demand for ATP. This AMPK
response to exercise has been found to notably decrease in red quadriceps (RQ)
following training, while putative AMPK roles such as increased GLUT4 and
hexokinase II expression and mitochondrial biogenesis are maintained (12). One
possible explanation for the attenuating effects of training on the AMPK response to
exercise is that perhaps the metabolic stress of trained muscle fibers during stimulation
has been reduced due to the cellular adaptations to exercise that took place during
training (increased GLUT4, blood supply, and mitochondria). Adaptations such as
these increase cellular capacity to produce ATP. Thus, the increased AMP:ATP ratio
required to maximize AMPK activation would be expected to be lower in trained rats
than in untrained rats that lack these adaptations.
It is also possible that the AMPK activity threshold needed to elicit such
changes is lower than expected or that it is decreased with training. Despite what is
actually taking place to account for the endurance-trained attenuation of the AMPK
response to exercise, it is also interesting to note that although AMPKK protein
abundance has been shown to increase in skeletal tissue with endurance training, its
level of activity has been shown to decrease with endurance training in both trained
and untrained tissue (22, 23, 44, 45). Currently, the activity of AMPKK immediately
following a 2-hr bout of exercise of an endurance-trained rat is unclear. It is possible
that there exists a direct link between the observed decrease in AMPKK activity in
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endurance-trained skeletal muscle and the attenuated AMPK response to exercise with
endurance training.
It has already been found that high-intensity work rates are needed for AMPK
activation (13, 24, 33, 56). Metabolic adaptations in skeletal muscle brought about by
endurance training may increase the work rate level of intensity needed to bring about
maximized activation of AMPK. Accordingly, we hypothesized that the AMPK
response to a given submaximal bout of exercise would be progressively increased
during a 2-hr bout of exercise at a high work rate (12). This study investigated the
effects of endurance training on the AMPK response to exercise; specifically, whether
the phosphorylation and activity of AMPK in RQ increases in rats after a 2-hr training
bout of exercise following an 8 wk training regimen. Results obtained from trained
rats that ran for 2 hrs (TR2) were compared to results from trained rats that ran for 30
min (TR1) or not at all (TRC). Understanding patterns of AMPK activity during
exercise and under conditions of training will help us to better understand its role in
energy metabolism as well as the importance of exercise as a conditional treatment for
metabolic diseases such as Type II diabetes.

MATERIALS AND METHODS
Animal care. All procedures were approved by the Institutional Animal Care and Use
Committee of Brigham Young University. Thirty male Sprague-Dawley rats (Sasco,
Wilmington, MA) were housed in a temperature-controlled (21−22°C) room that
cycled daily with a 12-hr light and 12-hr dark period. Rats were kept in rodent
shoebox compartments (two rats per compartment) with a metal grill top to allow for
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ventilation. Rodent bedding was replaced in each shoebox two times a wk and all rats
were weighed every wk to keep a log of rat growth rate. Rats were fed standard rat
chow (Harlan Teklad rodent diet) and given water to drink ad libitum. Rats were given
30 g of rat chow the night before they were killed.
Muscle stimulation. 18 randomly assigned rats (n = 6/group) were run on a motordriven rodent treadmill up a 15% incline 5 days/wk for 8-10 wks in a temperature
controlled room (16−17°C). The rats were run for 35 min the first day up a 5% incline
at 16 m/min. Exercise bout intensity was increased daily until the rats eventually
progressed to a single 120 min bout of exercise on a 15% incline at 30 m/min. Rat
training at this point was maintained for 4 more wks.
Muscle collection & homogenization. After 12 wks, blood and tissue samples
(left/right red/white quadriceps, and left/right soleus) were collected from trained rats
anesthetized either at rest or immediately following a 30-min or 2-hr bout of exercise
by intravenous (jugular catheter) injection of pentobarbital sodium. The catheters were
placed in the jugular veins of trained rats anesthetized with Isoflurane USP (liquid for
inhalation) 3 days prior to being killed. Once extracted, tissues were compressedfrozen with metal tongs at liquid nitrogen temperature, wrapped immediately in
labeled aluminum foil and then placed in a container filled with liquid nitrogen until
they were moved to an ultra-low temperature (−90°C) freezer for storage. Untrained
rats (n = 10) were anesthetized with pentobarbital sodium (50mg/kg body wt) and
tissues (right red/white quadriceps and right soleus) were extracted and clamp-frozen
at liquid nitrogen temperature. All tissues were ground with a ceramic mortar and
pestle at liquid nitrogen temperature and then homogenized in a homogenization

34

buffer containing 250 mM mannitol, 50 mM Tris-HCl, 50 mM NaF, 5 mM NaPPi, 1
mM EDTA, 1 mM EGTA, and 1% triton, all at a pH of 7.4. 1 mM Dithiothreitol
(DTT), 1 mM Benzamidine, 1μg/ml soybean trypsin inhibitor, and .5 mM AEBSF
were added to the buffer just prior to homogenization. The final concentration of the
tissue in the homogenization buffer solution was a 9 factor dilution (1 g muscle
powder/9 ml buffer). Approximately 300 μl of raw homogenate was stored and the
remainder was centrifuged at 2100 rpm for 20 min at 4°C. Post-centrifugation,
supernatant from the homogenate was immediately taken from the tubes and aliquots
were dispensed into 1500 μl Eppendorf tubes.
Western blots. Data obtained by comparison of protein content across all treatment
groups were collected from RQ, SOL, and WQ. Western blots were performed as
previously described (48). First antibody dilutions were cytochrome C, hexokinase II
(1:1,000 and 1:2,000 resp.; Santa Cruz Biotechnology, Santa Cruz, CA); PGC-1
(1:1,000; Chemicon International, Temecula, CA); phospho-CREB (Ser133),
phospho-ACC (Ser79), phospho-AMPK (Thr172) (1:5,000, 1:2,000, and 1:2,000
resp.; Cell Signaling Technology, Boston, MA); and UCP-3 (1:2,000; ABR Affinity
BioReagents, Golden, CO). Second antibody dilutions were anti-mouse horseradish
peroxidase (HRP)-linked antibody from donkey and anti-goat HRP-linked antibody
from donkey (1:5,000 and 1:5,000 resp.; Santa Cruz Biotechnology, Santa Cruz, CA);
and anti-rabbit HRP-linked antibody from donkey (1:5,000; Amersham Pharmacia,
Piscataway, NJ). Blots were developed with ECL/ECL Plus Western blotting detection
reagents (Amersham). Stripping and reprobing was carried out (when applicable)
according to the manufacturer’s instructions (ECL, Amersham).
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Citrate synthase assay. Aliquots from raw tissue homogenates of RQ, SOL, and WQ
were slow-frozen at –20°C overnight and subjected to two additional freeze-thaw
cycles. All tissue homogenates were prepared in homogenization buffer (250 mM
mannitol, 50 mM Tris-HCl, 50 mM NaF, 5 mM NaPPi, 1 mM EDTA, 1 mM EGTA,
1% triton all at a pH of 7.4). Proteolytic enzyme inhibitors were added immediately
before preparation of the homogenates (1 mM Dithiothreitol (DTT), 1 mM
Benzamidine, 1 μg/ml soybean trypsin inhibitor, 0.5 mM 4-(2aminoethyl)benzenesulfonyl fluoride (AEBSF)). Citrate synthase was assayed
according to the method of Srere (39).
Blood glucose assay. Blood glucose (mM) was measured as previously described (3).
AMPK activity assay. All AMPK activity data were collected from RQ. AMPK was
isolated by immunoprecipitation from spun (~950 x g) cell homogenate of all trained
rats. G-sepharose bound to anti-AMPK-α2 incubated with muscle homogenates
overnight on a vertically rotating mixer at 4°C. The following day, the
immunoprecipitates were washed twice with ice-cold immunoprecipitation (IP) buffer
(50 mM Tris-HCl, 150 mM NaCl, 50 mM NaF, 5mM Na pyrophosphate, 1 mM
EDTA, 1 mM EGTA, 1 mM DTT, 1 mM DTT, 1 mM benzamidine, 0.1 mM PMSF, 5
ug/ml soybean trypsin inhibitor, pH 7.4) + 1M NaCl to remove non-specific proteins
and then once with IP buffer without the 1 M NaCl. Hepes buffer (25 mM HEPES,
0.02% Brij, 1 mM DTT, pH 7.0) was added to resuspend the IP pellet and prepare the
immunoprecipitates for the AMPK assay. Next, the immunoprecipitates were evenly
aliquotted (10 μl) in duplicate into 12 x 75 glass tubes. Working cocktail was then
added to start the reaction. Final concentrations in the assay mix were 40 mM Hepes,
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0.2 mM AMARA peptide (Zinsser Analytical, Maidenhead, Berkshire, UK), 0.2 mM
AMP, 80 mM NaCl, 8% glycerol, 0.8 mM EDTA, 0.8 mM DTT, 5 mM MgCl2, 0.2
mM ATP, 2 μCi 32P-ATP/tube, pH 7.0. After incubating for 10 min at 37°C, 15 μl
from each tube was transferred to a labeled 1 x 1 cm Whatman P81 filter paper. The
filter papers were then rinsed 5 times in fresh 1% phosphoric acid (5 min/wash), rinsed
once with acetone, and allowed to dry. Dry papers were placed in scintillation vials
containing 3 ml EcoLite scintillation cocktail (ICN Research Products Division, Costa
Mesa, CA), placed in a Beckman scintillation counter, and counted for 5 min each.
AMPK activity measured in pmol.min-1.mg-1 was converted from the counts per min
detected by the scintillation counter.
Statistics. Comparisons of relative protein abundances, blood glucose concentrations,
or enzyme activities between treatment groups were made using one-way ANOVA.
When main effects reached significance, Fisher's least significant difference multiple
comparison test was used to determine the location. Student’s t-test was used to detect
significant differences between trained and untrained muscle fiber protein abundances
and citrate synthase activities in RQ, SOL, and WQ. For all tests, statistical
significance was set at P < 0.05. Student’s t-tests were performed with Microsoft
Office Excel 2003 technology (Microsoft, Redmond, Washington) while all other
statistical procedures were performed with the Number Cruncher Statistical Systems
program (NCSS, Kaysville, Utah). All data are reported as means ± SE.

37

RESULTS
Citrate synthase activity was measured to determine effectiveness of the
training program. Endurance training resulted in a statistically significant increase in
citrate synthase activity in both RQ and SOL but not WQ (P < .05) (Fig. 1A−C, n = 10
for untrained/control rats and n = 18 for trained rats).
Western blot analysis of phospho-AMPK (Thr172) in RQ revealed a
statistically significant increase in trained rats that ran for 30 min (TR1) and 120 min
(TR2) compared to trained/rested rats (TRC) (P < .05), whereas no significant change
was observed between TR1 and TR2 (Fig. 2A, n = 6). In SOL, phospho-AMPK
increased significantly (P < .05) between untrained/rested rats and trained rats, while
no significant change was observed between TRC, TR1, and TR2 (Fig. 2B, n = 10 for
UTR and n = 6 for TRC, TR1, and TR2). No significant change in phospho-AMPK
protein content was found between any treatment groups in WQ (Fig. 2C, n = 10 for
UTR and n = 6 for TRC, TR1, and TR2). Furthermore, an analysis of AMPK activity
revealed a statistically significant increase in TR1 and TR2 compared to TRC (P
< .05) showing that phospho-AMPK protein content correlated (to some extent) with
AMPK activity (Fig. 3, n = 6).
Acetyl-CoA carboxylase (ACC) is a downstream target of AMPK. Since
allosteric activation of AMPK cannot be detected by the AMPK activity assay,
phospho-ACC was measured as an indicator of AMPK activation in the muscle.
Phospho-ACC (Ser79) increased similarly to phospho-AMPK in RQ. In RQ, a
statistically significant increase was found in TR1 and TR2 compared to TRC (P
< .05), yet no significant change was observed between TR1 and TR2 (Fig. 4A, n = 6).
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Phospho-ACC protein content was also similar to phospho-AMPK protein content in
SOL. In SOL, we found a significant increase in phospho-ACC between UTR and TR
(P < .05), while no significant change was observed between TRC, TR1, and TR2 (Fig.
4B, n = 10 for UTR and n = 6 for TRC, TR1, and TR2). No significant changes in WQ
phospho-ACC protein content were observed between any of the treatment groups
(Fig. 4C, n = 10 for UTR and n = 6 for TRC, TR1, and TR2).
CREB has been identified as a downstream target of many protein kinases,
including AMPK. Phospho-CREB (Ser133) in RQ was significantly increased
between UTR and TR (P < .05), but no significant change was observed between TRC,
TR1, and TR2 (Fig. 5, n = 10 for UTR and n = 6 for TRC, TR1, and TR2).
Hexokinase II and cytochrome C genes have CRE in their promoter regions
and serve as markers for CREB activity. In RQ and SOL, hexokinase II increased
significantly (P < .05) in trained rats relative to untrained/rested rats (Fig. 6A, and 6, n
= 10 for untrained/control and n = 18 for trained). Endurance training had no effect on
hexokinase II levels in WQ relative to untrained/rested rats (Fig. 6C, n = 10 for
untrained/control and n = 18 for trained). UCP-3 is a mitochondrial proton carrier and
serves as a marker for mitochondrial content and oxidative capacity. UCP-3 also
increased significantly (P < .05) in trained rats relative to untrained/rested rats in RQ
(Fig. 7, n = 10 for untrained/control and n = 18 for trained).
Cytochrome C increased significantly (P < .05) in trained rats compared to
untrained/rested rats in RQ and SOL (Fig. 8A−B, n = 10 for untrained/control and n =
18 for trained), while no change was observed in WQ (Fig. 8C, n = 10 for
untrained/control and n = 18 for trained).
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Measurement of blood glucose (mM) in trained rats revealed that blood
glucose levels decreased significantly in TR1 and TR2 compared to TRC (P < .05).
Beyond 30 min of treadmill exercise of trained rats, blood glucose levels appeared
stable as no significant change in blood glucose was observed between TR1 and TR2
(Fig. 9, n = 6).

DISCUSSION
A previous study found that in RQ, the AMPK activity of endurance-trained
rats decreased compared to sedentary controls in response to a 10 min bout of exercise
(7). This observation suggested that, in some form or another, endurance training does
have an attenuating effect on the AMPK response to exercise. We know that AMPK is
activated in muscle fibers when the muscle fiber is experiencing a high energy
challenge. We hypothesized that perhaps the attenuating effects that endurance
training has on the AMPK response to exercise may be due to the cellular adaptations
that take place during endurance training. The purpose of this study was to identify
whether or not AMPK activity would increase significantly in trained rat muscle (RQ)
after a 2-hr bout of exercise compared to trained rats that ran for 30 min. We found
that although rats in our study ran for an additional 110 min compared to the rats ran
in the previous study (12), no significant increases in AMPK activity were observed in
RQ beyond the 30 min mark. Although RQ phospho-AMPK protein, and AMPK
activity all increased significantly in trained/exercised rats relative to trained/rested
rats, we did not observe a significant climb in AMPK activity or phospho-AMPK
protein content in trained rats that ran for 2 hrs compared to those that ran for 30 mins.
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This suggests that continued adaptations to training [increased hexokinase II, GLUT4,
and mitochondria in rat RQ] are not due to a maximized AMPK response after 2 hrs of
exercise.
Though no maximal response was observed, AMPK activity and phosphoAMPK content in our study did increase in response to the exercise. This response is
notably lower than what can be observed in untrained muscle fiber in response to
exercise (12). Despite these observations, we still observed marked increases in
metabolic factors as well as mitochondrial activity (Fig. 1/Fig. 3a/Fig. 5a, 5c/Fig. 6a).
It is likely that other signals, downstream of AMPK, are maintaining the AMPK signal
to the extent that maximal AMPK activation is no longer required in endurancetrained muscle fiber. To investigate other downstream targets of AMPK that may be
maintaining the AMPK signal in trained rats, we decided to investigate phosphoCREB content at the serine 133 position (phospho-CREB); the site phosphorylated by
AMPK.
When activated, CREB acts as a transcription factor known to regulate the
expression of several proteins involved in metabolic processes (2). It does this by
binding to the cyclic AMP response element (CRE) of those genes involved in various
cellular functions, including metabolism. Once bound to CRE sites, CREB can
facilitate the transcription of these genes which will, in turn, yield proteins that can
cause cells to differentiate, divide (30, 38, 43, 58), or adapt to cellular stresses,
including those metabolic stresses that take place during exercise and endurance
training.
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A recent study has shown that endurance training results in increased phosphoCREB in skeletal muscle after 15 hrs of rest (36). Here, we also show that endurance
training increases p-CREB and that this signal is maintained for at least 24 hrs after
the most recent bout of exercise as we observed no significant change in phosphoCREB content between TRC, TR1, and TR2 rats. This did not correlate with phosphoAMPK expression as levels dropped after the 24 hr period of rest. This suggests that
either AMPK is not responsible for the maintained phosphorylation of CREB at serine
133, or that the attenuated AMPK activity during rest is still above the threshold
required for CREB phosphorylation. These data suggest that a long-lasting signal in
the form of phospho-CREB may extend the signal for increasing training induced
enzyme changes far beyond the end of each exercise bout.
It is already known that CREB expression correlates positively with PGC-1
expression, endurance training, mitochondrial respiratory capacity, exercise, and
mitochondrial gene expression (2, 36, 50, 51). Our results show that CREB is
phosphorylated in endurance-trained rats and that it remains phosphorylated during
times of rest when AMPK is less active and during exercise when we show AMPK
activity increased (see Fig. 4). Accordingly, it is possible that an extended CREB
signal in endurance-trained muscle extends effects of contraction induced signals even
during times of rest. Endurance-trained attenuation of the AMPK response to exercise
would then be the result of less metabolic stress felt by the cell, and thus an attenuated
demand for AMPK activity.
CREB also plays a part in coordinating the differentiation of several tissues,
including adipose and endocrine (19, 34). Our study suggests a possible role for CREB
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in which it is also differentiating muscle tissue into a phenotype consistent with
cellular adaptations to endurance training when it is phosphorylated either by AMPK
or by other upstream kinases such as PKA or CaMKII. Although other signaling
pathways, such as CREB, may help to give an explanation for the endurance-trained
attenuation of the AMPK response to exercise, we are still unclear whether these
pathways are solely responsible. Other details fundamental to the activity and
regulation of AMPK itself may help to give meaning to the marked increases in RQ
adaptations to endurance training. Specifically, the reasons underlying AMPK
attenuation in endurance-trained muscle fiber may help to account for these
adaptations.
Although a 2-hr bout of treadmill running was not enough to maximize AMPK
activation in endurance-trained RQ to the extent at which it is activated in untrained
RQ (12), adaptations to the endurance training may have played a part in lessoning the
demand for AMPK activation. Consequential to these adaptations to endurance
training, muscle fiber capacity to produce ATP in this study will have increased in
endurance-trained rats relative to control. It is likely that this will have resulted in an
attenuation of the exercise-induced increases of the AMP:ATP ratio required for
AMPK activation. Attenuation of the exercise-induced increase of the AMP:ATP ratio
has already been shown in a previous study of the effects of short-term training on
AMPK activation with prolonged exercise (27). That said, although AMPK activity
and phospho-AMPK protein content did increase in trained RQ in response to exercise,
maximal AMPK activity in RQ may only be required early in the training process
prior to the onset of the increase in mitochondrial enzymes which act to increase ATP.
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Accordingly, maximal AMPK activity may only be observed in muscle when
adaptations to training are in maximal demand; untrained muscle exposed to highintensity endurance training or trained muscle exposed to a training regimen with
substantial increases in work rate intensity.
It is also possible that a 2-hr bout of treadmill exercise was not enough to
sufficiently stress muscle fibers to the extent that maximal AMPK activation is
required. Other tactics implemented on the final bout of exercise may be useful in
activating AMPK in trained muscle to the same extent at which it is activated in
untrained muscle (12). It has already been demonstrated that interval training regimens
serve as an effective approach to AMPK activation (45). Perhaps subjecting trained
rats to a high-intensity bout of interval exercise will prove enough to exhaust
endurance trained RQ to the extent that maximal activation of AMPK is needed. Rats
subjected to fasting may also elicit greater metabolic demands for maximal AMPK
activation in trained RQ (10, 11, 15).
In summary, our results provide evidence that the continued adaptations to
training in RQ, aside from the attenuated AMPK response to exercise, are not due to a
delayed, yet maximal AMPK response at the end of a 2-hr bout of exercise;
presumably where the metabolic demand for maximized AMPK activity would be the
greatest. However, the premise that maximal AMPK activity is required in endurancetrained RQ in order to elicit such adaptations is a matter needing further investigation.
To our knowledge, no investigation has been carried out to elucidate the necessary
AMPK threshold required to yield endurance-trained adaptations in muscle,
specifically in RQ. Nevertheless, studies have revealed that low-intensity exercise
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(and presumably, relatively low AMPK activity) was sufficient to increase AMPK
activity beyond the putative threshold needed to elicit adaptations to exercise such as
increases in both PGC-1 mRNA and protein content in rat epitrochlearis, as well as
increases in PGC-1 protein content in soleus (46, 47). Consequently, the putative
threshold of AMPK activity required to elicit adaptations in skeletal muscle in
response to training may be lower then expected. For that matter, an attenuated AMPK
response to exercise in endurance-trained skeletal muscle may still be above the
putative threshold needed for AMPK to elicit biochemical adaptations to endurance
training. Alternatively, it is also possible that among the many adaptations to
endurance training which take place in skeletal muscle, an increased cellular
sensitivity to AMPK activation may also be prevalent. This would suggest that
endurance-trained skeletal muscle would be poised to respond to AMPK activation
during exercise to a greater extent than untrained skeletal muscle. Thus, an attenuated
demand for maximal AMPK activation would be observed not only for the increased
capacity of the muscle fiber to produce ATP, but also for an increased sensitivity to
AMPK activation.
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FIGURE LEGENDS

Figure 1
Citrate synthase activity in rat RQ (A), SOL (B), and WQ (C) of control, and
endurance-trained rats measured in µmol/g/min. Values are means ± SE (n = 10 for
control and n = 18 for trained). *Citrate synthase values were significantly different
from control value (P < 0.05).

Figure 2
Western blot analysis of the phosphorylation of AMPK as measured by relative
protein quantities of phosphothreonine-172 AMPK (P-AMPK). P-AMPK content was
measured either between the three trained groups (TRC, TR1, and TR2) or between all
groups (UTR, TRC, TR1, and TR2). (A) Relative P-AMPK content in RQ. (B)
Relative P-AMPK content in SOL. (C) Relative P-AMPK content in WQ.
†Significantly different from TRC. *Significantly different from UTR (n = 6−10, P <
0.05).

Figure 3
Immunoprecipitation to determine AMP-activated protein kinase (AMPK) activity in
endurance-trained rat RQ after running 0 min (TRC), 30 min (TR1), or 2 hrs (TR2)
measured in pmol.min-1.mg-1. Values are means ± SE (n = 6). †AMPK activity was
significantly greater compared to the TRC control (P < 0.05).
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Figure 4
Western blot analysis of the phosphorylation of ACC by AMPK as measured by
relative protein quantities of phosphoserine-79 ACC (P-ACC). P-ACC content was
measured either between the three trained groups (TRC, TR1, and TR2) or between all
groups (UTR, TRC, TR1, and TR2). (A) Relative P-ACC content in RQ. (B) Relative
P-ACC content in SOL. (C) Relative P-ACC content in WQ. †Significantly different
from TRC. *Significantly different from UTR (n = 6−10, P < 0.05).

Figure 5
Western blot analysis of the phosphorylation of CREB at the AMPK phosphorylation
site (Ser133) as measured by relative protein quantities of phosphoserine-133 CREB
(P-CREB). P-CREB content was measured in rat RQ all groups (UTR, TRC, TR1, and
TR2). *Significantly different from UTR (n = 6−10, P < 0.05).

Figure 6
Hexokinase II protein relative abundance in rat RQ (A), SOL (B), and WQ (C) of
control (UTR), and endurance-trained (TR) rats. Values are means ± SE (n = 10 for
UTR and n = 18 for TR). *Hexokinase II values were significantly greater than UTR
control value (P < 0.05).
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Figure 7
UCP-3 protein relative abundance in rat RQ of control (UTR), and endurance-trained
(TR) rats. Values are means ± SE (n = 10 for UTR/untrained and n = 18 for
TR/trained). *UCP-3 value was significantly greater than UTR control value (P <
0.05).

Figure 8
Cytochrome C protein relative abundance in rat RQ (A), SOL (B), and WQ (C) of
control (UTR), and endurance-trained (TR) rats. Values are means ± SE (n = 10 for
UTR and n = 18 for TR). *Cytochrome C values were significantly greater than UTR
control value (P < 0.05).

Figure 9

Blood glucose concentrations (mM) in TRC, TR1, and TR2 rats. †Significantly
different from TRC (n = 6, P < 0.05).
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(Relative Units)

Hexokinase II

A

3.5
3.0

*

UTR
TR

2.5
2.0
1.5
1.0
0.5
0.0
UTR

(Relative Units)

Hexokinase II

B

1.4

UTR

1.2

TR

TR

*

1.0
0.8
0.6
0.4
0.2
0.0

C

1.2

UTR

TR

UTR

TR

UTR
TR

(Relative Units)

Hexokinase II

1.0
0.8
0.6
0.4
0.2
0.0

63

Figure 7
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Figure 8
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